Topics

Pear Therapeutics Company Profile

22:05 EDT 15th September 2019 | BioPortfolio

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approved pharmaceuticals and treatment paradigms to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear’s lead product, reSET®, is an FDA-cleared 12-week interval prescription therapeutic for Substance Use Disorder to be used as an adjunct to standard, outpatient treatment. Pear’s product development pipeline includes reSET®-O™ for opioid use disorder (OUD) and additional prescription digital therapeutics in schizophrenia (Thrive™), combat posttraumatic stress disorder (reCALL™), general anxiety disorder (reVIVE™), pain, major depressive disorder, and insomnia, for which Pear intends to obtain FDA clearance. For more details, please see www.peartherapeutics.com.


News Articles [948 Associated News Articles listed on BioPortfolio]

Pear Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference 

Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Operating Officer, will...

Pear Therapeutics to Participate in the Oppenheimer Summit for Emerging Biotechnology

Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Ope...

Pear Therapeutics to Present at Oppenheimer’s 29th Annual Healthcare Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Ch...

Pear Therapeutics submits marketing application to FDA for digital therapeutic Somryst

The company has filed a marketing application to the FDA for Somryst to treat adults with chronic insomnia and depression. Somryst is claimed to be the first product The post Pear Therapeutics submit...

Prominent New York Times Health Care Reporter Robert Pear Dies At 69

Robert Pear spent 40 years at The New York Times covering the ins and outs of health care politics and policy, among other national issues. His paper's obituary describes Pear as someone who "influenc...

How Digital Therapeutics Developers Can Satisfy Diverse Stakeholder Needs

If there are lingering doubts about the viability or market potential of digital therapeutics (DTx), recent moves by the U.S. Food & Drug Administration should lay them to rest. In December 2018, ...

You Want Patient Engagement? Make The System Navigable

Irv Lichtenwald, President & CEO of  Medsphere Systems Corporation Last month, New York Times reporter Robert Pear died at age 69 from complications of a stroke. The name was unfamiliar to me, ...

Pear Therapeutics to Present Data on reSET®, for the Treatment of Substance Use Disorder, and Pear-004, for the Treatment of Schizophrenia, at American Psychiatric Association Annual Meeting

Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced poster and oral presentations for the American Psychiatric Association Annu...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [467 Associated PubMed Articles listed on BioPortfolio]

Effective degradation of the mycotoxin patulin in pear juice by porcine pancreatic lipase.

Porcine pancreatic lipase (PPL) was used to degrade the mycotoxin patulin (PAT) in pear juice. The dosage of PPL, the initial concentration of PAT, reaction temperature and time were investigated by b...

Methyl salicylate delays peel yellowing of 'Zaosu' pear (Pyrus bretschneideri) during storage by regulating chlorophyll metabolism and maintaining chloroplast ultrastructure.

In some cultivars, yellowing resulting from chlorophyll breakdown has a direct and negative effect on food supply and health. The 'Zaosu' pear (Pyrus bretschneideri Rehd.), a commercial Asian pear cul...

Pear Extract and Malaxinic Acid Reverse Obesity, Adipose Tissue Inflammation, and Hepatosteatosis in Mice.

Obesity and diabetes are major public health problems and are emerging as pandemics. Considerable evidence suggests that pear fruit consumption is associated with a lower risk of obesity-related compl...

Genome sequence resource for Stemphylium vesicarium, causing Brown Spot Disease of Pear.

Stemphylium vesicarium is the causal agent of several plant diseases as well Brown Spot of Pear (BSP), which is one of the most economically important fungal diseases in European pear-production areas...

Identification of hexokinase family members in pear (Pyrus × bretschneideri) and functional exploration of PbHXK1 in modulating sugar content and plant growth.

Hexokinase (HXK) is a multifunctional protein that serves as a sugar sensor for glucose signaling and a catalyst for glycolysis. It has been well studied in many species, however, there is far less in...

Clinical Trials [188 Associated Clinical Trials listed on BioPortfolio]

Study of Efficacy of PEAR-004 in Schizophrenia

The purpose of the study is to determine in patients currently being administered antipsychotic pharmacotherapy whether PEAR-004 can further reduce symptoms of schizophrenia as measured by...

Evaluation of Activity Levels, Inflammatory Markers, and Overall Wellness.

The purpose for this protocol is to perform a double-blind, randomized, placebo-controlled, parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical prod...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1371 Associated Companies listed on BioPortfolio]

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approv...

Pear Therapeutics, Inc.

Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based th...

Pear Bureau Northwest

Pear Bureau Northwest is the non-profit marketing organization established in 1931 to promote the fresh USA Pears grown in Washington and Oregon. Together, these two states represent 1,600 growers and...

PEAR Sports, LLC

Developed by a passionate team of entrepreneurs with athletic, technology and design backgrounds, PEAR Sports was born from the desire to offer game-changing personalized coaching...

Senti Biosciences

Senti Biosciences is a next-generation therapeutics company that is developing gene circuits and programming cells for tremendous therapeutic value. Our mission is to outsmart com...

More Information about "Pear Therapeutics" on BioPortfolio

We have published hundreds of Pear Therapeutics news stories on BioPortfolio along with dozens of Pear Therapeutics Clinical Trials and PubMed Articles about Pear Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pear Therapeutics Companies in our database. You can also find out about relevant Pear Therapeutics Drugs and Medications on this site too.

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record